Nexletol is Esperion’s brand name for bempedoic acid, a once-daily tablet that lowers LDL cholesterol by a different mechanism than statins. Nexlizet is the same drug packaged with 10 mg of ezetimibe. FDA approved both in February 2020, and on March 22, 2024 approved broad new labels based on the CLEAR Outcomes trial, adding cardiovascular risk reduction for adults who are unable to take recommended statin therapy, including those not taking a statin at all.
That label is why this page exists. Most people asking what Nexletol costs are asking because the cheap options are off the table for them, and the answer is uncomfortable: this is a brand-only drug at roughly $400 to $600 a month, and the manufacturer’s discount card is closed to anyone without commercial insurance. Everything below was researched on September 3, 2026.
What Does Nexletol Cost Without Insurance?
The acquisition-cost anchor is CMS NADAC, the federal survey of what pharmacies actually pay, using the vintage effective August 19, 2026. Retail cash figures come from Drugs.com and SingleCare, both read September 3, 2026. Comparison prices for the generic alternatives come from NADAC and Cost Plus Drugs.
| Option | Low | Average | High |
|---|---|---|---|
| Nexletol 180 mg, 30 tablets, cash | $390.48 | $430.55 | $593.03 |
| Nexlizet 180-10 mg, 30 tablets, cash | $392.46 | $430.55 | $606.03 |
| Nexletol, 30-day NADAC acquisition cost | $414.17 | $414.17 | $414.17 |
| Nexlizet, 30-day NADAC acquisition cost | $414.42 | $414.42 | $414.42 |
| Co-pay card, 30-day supply (commercial insurance only) | $10 | $10 | $10 |
| Co-pay card, 90-day supply (commercial insurance only) | $25 | $25 | $25 |
| Generic ezetimibe, 30 days, for comparison | $6.38 | $6.38 | $19.44 |
| Generic statin, 30 days, NADAC acquisition cost | $0.70 (atorvastatin 10 mg) | $1.11 (atorvastatin 40 mg) | $2.08 (atorvastatin 80 mg) |
The arithmetic on the NADAC lines: CMS recorded Nexletol 180 mg at $13.80559 per tablet and Nexlizet 180-10 mg at $13.81411 per tablet effective August 19, 2026. Multiply either by 30 and you get $414.17 and $414.42 respectively. That is what a pharmacy pays to stock a month of it, so any cash quote below roughly $410 is a pharmacy selling near or below its own cost.
The three published cash sources agree more than they disagree. Drugs.com puts 30 tablets at $430.55 ($14.35 each), NADAC puts the acquisition cost at $414.17, and SingleCare’s card price of $390.48 sits just below both. The outlier is SingleCare’s $593.03 average retail figure, which represents an unhelped counter fill.
The list price has drifted up since launch
When Esperion made Nexletol commercially available on March 30, 2020, its own announcement described the drug as available “at a list price of around $10 per day to payers.” Six years later the federal acquisition-cost survey puts it at $13.81 a day. That is roughly a 38% increase in the number a pharmacy pays, on a drug that launched with affordability as an explicit selling point.
What Drives the Price
There is no generic, and there is no near-term prospect of one. FDA’s Drugs@FDA database lists Nexletol under NDA 211616 and Nexlizet under NDA 211617, both Esperion, both approved February 2020, with no approved abbreviated applications behind either. NADAC has no generic bempedoic acid row. Until that changes, the brand price is the only price.
Your insurance status decides whether the discount exists. This is the unusual part. On most brand drugs an uninsured cash payer has some path to the manufacturer’s help. Here the only published program is a co-pay card that requires commercial prescription insurance.
Nexletol and Nexlizet cost the same. The two products are within a penny per tablet of each other at acquisition cost. The ezetimibe in Nexlizet, which costs about $6 a month on its own, adds nothing to the price.
Which pharmacy you walk into. The spread between SingleCare’s card price and its average retail figure on the identical 30 tablets is $202.55, more than a third of the higher number.
Quantity. The co-pay card’s own terms price a 90-day supply at $25 rather than $30, and 90-day fills generally carry a lower per-month dispensing cost even on cash. Ask for the 90-day quote before you accept the 30-day one.
Cash Price vs. Insurance
For this drug the gap between insured and uninsured is as wide as it gets. Esperion’s HCP access page states that in the third quarter of 2024, Medicare patients paid an average of $43 for a 30-day supply. A commercially insured patient using the co-pay card pays $10. An uninsured cash payer pays $390 to $593.
The eligibility terms are explicit and worth reading before you spend time on an application. Esperion requires that the patient be at least 18, hold a valid prescription, have commercial prescription drug insurance, and reside in the United States excluding territories. It separately excludes anyone enrolled in a state, federal or government-funded healthcare program including Medicare, Medicaid, Medigap, TRICARE or VA coverage. Esperion also notes that some plans require prior authorization, with diagnosis, statin history and current LDL-C level.
There is a real strategic point buried in that. If you are uninsured and this drug is genuinely the plan, the cost of insurance itself may be the cheaper variable. A marketplace plan that gets you to a $10 co-pay card changes the annual math on this one prescription by several thousand dollars. Our self-pay vs. health insurance breakdown covers how to run that comparison honestly.
Also budget for the monitoring, not just the tablets. Lipid panels and follow-up visits are recurring costs on any cholesterol regimen, and blood work without insurance is often the part people forget to price.
How to Pay Less
-
Get a written cash quote from more than one pharmacy before you fill. The published spread on this drug is $390 to $593 for the same 30 tablets. That is a $200 difference for making two phone calls. Our fair price checker helps sanity-check whatever number you are given.
-
Run a discount card even though it is a brand drug. SingleCare’s card price of $390.48 was below both the Drugs.com cash price and the federal acquisition cost when we checked on September 3, 2026. Card prices on brand drugs move, so check more than one. Our comparison of GoodRx vs. SingleCare covers running both on the same fill.
-
Ask about the 90-day fill. Esperion’s own card prices a 90-day supply at $25 against $10 for 30 days, which tells you the channel is built for longer fills. Even on cash, fewer dispensing events usually means a lower per-month total.
-
Price the generic alternatives before you commit. Generic ezetimibe costs $6.38 for 30 tablets at Cost Plus Drugs. Generic atorvastatin and rosuvastatin cost roughly a dollar a month at federal acquisition cost. If a statin is an option for you, the difference is not marginal, it is a factor of several hundred. That is a prescriber conversation, not a decision to make at the counter.
-
Ask the prescriber’s office to file the prior authorization properly. Esperion’s own guidance says including diagnosis, statin history and LDL-C level helps approval. If you have any coverage at all, an approved prior authorization is worth more than any discount card.
-
Use a low-cost prescriber for the ongoing management. A free or sliding-scale clinic can handle the visits and lipid monitoring at little or no cost, which keeps the non-drug half of the budget down. If hospital bills from a cardiac workup are already outstanding, our guides to charity care and negotiating medical bills are the next stop.
Bottom Line
Budget $390 to $593 a month for Nexletol or Nexlizet if you are paying cash, and expect to land near $415 to $430, which is where the acquisition cost and the two published retail figures cluster. There is no generic, no uninsured assistance track on Esperion’s patient site, and no cheaper version of this molecule anywhere.
For context on the rest of the cholesterol shelf, generic ezetimibe costs about $6 a month and the generic statins cost about $1, which makes Nexletol roughly sixty times the price of the cheapest oral option. On the other side, the injectables cost more still: see Repatha, Praluent and Leqvio. Nexletol sits in the middle of that range, which is exactly why the cash quote is worth shopping rather than accepting.